Adaptive Biotechnologies Corp (ADPT) — Cash Flow Reinvestment Rate

Latest as of March 2019: 0.81x

Adaptive Biotechnologies Corp (ADPT) has a Cash Flow Reinvestment Rate of 0.81x as of March 2019, reinvesting $226.01 Million (capex $3.83 Million plus investments $-222.18 Million) from operating cash flow of $278.30 Million. See ADPT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.81x
(Capex + Investments) / Operating CF

Total Reinvested

$226.01 Million
Capex + Investments

Operating Cash Flow

$278.30 Million
USD

Capital Expenditures

$3.83 Million
USD

Adaptive Biotechnologies Corp Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Adaptive Biotechnologies Corp across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Adaptive Biotechnologies Corp.

Annual Cash Flow Reinvestment Rate for Adaptive Biotechnologies Corp (2019–2019)

Year-by-year capital reinvestment analysis for Adaptive Biotechnologies Corp. See Adaptive Biotechnologies Corp free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 2.35x $481.70 Million $205.40 Million $11.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow